ESTELA ORTIZ: Open Payments
NPI 1578163812 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 66 payments from 14 companies in 2025. Trend: 2023 $916 · 2024 $664 · 2025 $1,018
Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $181 |
| PFIZER INC. | 18 | $171 |
| ABBVIE INC. | 13 | $148 |
| Dexcom, Inc. | 4 | $73 |
| Lilly USA, LLC | 4 | $67 |
| SANOFI-AVENTIS U.S. LLC | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: NURTEC ODT, BREZTRI, QULIPTA, Wegovy, Dexcom G6 Transmitter, AIRSUPRA, TZIELD, UBRELVY.
Industry payments across TX — which companies pay providers there.
